$2.43 +0.10 (4.29%)
Estrella Immunopharma, Inc. Common Stock (ESLA)
Estrella Immunopharma, Inc. (ESLA) is a biotechnology company focused on developing innovative therapies aimed at immune modulation and autoimmune diseases. The company leverages advanced immunological research to create treatments intended to improve patient outcomes in various immune-related conditions.
Company News
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers RiskOn International, Inc. (NASDAQ: ROI) shares rose 51.3% to $0.2250 in p...